The French government is preparing to tighten regulations on the rapidly growing dietary supplement market. A draft decree, examined on July 16th, aims to restrict the sale of certain sensitive substances to pharmacies only. This move is a response to concerns about products sold online and in pharmacies with insufficient oversight. The regulations will be based on substance dosage and potential interactions with prescription medications. This represents the first significant attempt to control a previously largely unregulated market. The goal is to increase consumer safety and ensure responsible sales practices within the sector. This action addresses the increasing availability of these products and the need for greater control over their distribution.